References
- Pap T, Muller LU, Gay RE, Gay S. Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000;2:361-7. https://doi.org/10.1186/ar113
- Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada K. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000;59:455-64. https://doi.org/10.1136/ard.59.6.455
- Avina-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690-7. https://doi.org/10.1002/art.24092
- Crisp AJ, Armstrong RD, Grahame R, Dussek JE. Rheumatoid lung disease, pneumothorax, and eosinophilia. Ann Rheum Dis. 1982;41:137-40. https://doi.org/10.1136/ard.41.2.137
- Joana FF, Alaa AAM, Paul E. Glucocorticoids and Rhematoid Arthritis. Rheum dis Clin North Am. 2016;42:33-46. https://doi.org/10.1016/j.rdc.2015.08.006
- Taukumova LA, Mouravjoy Yu V, Gribakin SG. Mucocutaneous side effects and continuation of aurotherapy in patients with rheumatoid arthritis. Adv Exp Med Biol. 1999;455:367-73.
- Kim YJ, Song M, Ryu JC. Inflammation in methotraexate- induced pulmonary toxicity occurs via the p38 MAPK pathway. Toxicology. 2009;256:183-90. https://doi.org/10.1016/j.tox.2008.11.016
- Konttinen TY, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, Kinne R, Santavirta S, Sorsa T, Lopez-Otin C, Takagi M. Analysis of 16 different matrix metallo proteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis. 1999;58:691-7. https://doi.org/10.1136/ard.58.11.691
- Jackson C, Nguyen M, Arkell J, Sambrook P. Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis-targetting gelatinase A activation. Inflamm Res 2001;50:183-6. https://doi.org/10.1007/s000110050743
- Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis Annu Rev Immunol. 1996;14:397-440. https://doi.org/10.1146/annurev.immunol.14.1.397
-
Noh EM, Kim JS, Hur H, Park BH, Song EK, Han MK, Kwon KB, Yoo WH, Shim IK, Lee SJ, Youn HJ, Lee YR. Cordycepin inhibits IL-
$1{\beta}$ -induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts. RHEUMATOLOGY. 2009;48:45-8. - Kim CM, Shin MK, Lee KS, Ahn DK. Great Dictionary of chinese Medicine. Junngdam, Seoul, Press 1999;pp 369-71.
- Hwang JK, An CG, Kim SC, Lee SH, Park SH, Ryu DG, Lee GS, Lee YR, Kim BS, Kwon KB. Extracts of Desmodii Herba Inhibits of TPA-induced invasion in MCF-7 Human Breast Carcinoma Cells. Journal of Physiology & Pathology Korean Medicine. 2014;28:494-8.
- Hwang JK, Noh EM, Moon SJ, Kim JM, Kwon KB, Park BH, You YO, Hwang BM, Kim HJ, Kim BS, Lee SJ, Kim JS, Lee YR. Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice. Rheumatology. 2013;52:1583-91. https://doi.org/10.1093/rheumatology/ket178
- Pretzel D, Pohlers D, Weinert S, Kinne RW. In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage. Arthritis Res Ther. 2009;11:R25. https://doi.org/10.1186/ar2618
- Rooney T, Roux-Lombard P, Veale DJ, FitzGerald O, Dayer JM, Bresnihan B. Synovial tissue and serum biomarkers of disease activiy, therapeutic response and radiographic progression: analysis of a proof-of-concept randomised clinical trial of cytokine blockade. Ann Rheum Dis. 2010;69:706-14. https://doi.org/10.1136/ard.2009.108324
- Paunovic V, Harnett MM. Mitogen-activated protein kinases as therapeutic targets for rheumatoid arthritis. Drgus. 2013;73:101-15. https://doi.org/10.1007/s40265-013-0014-6
- Filipovic I, Walker D, Forster F, Curry AS. Quantifying the economic burden of productivity loss in rheumatoid arthritis. RHEUMATOLOGY. 2011;50:1083-90. https://doi.org/10.1093/rheumatology/keq399
- Zhao S, Otieno F, Akpan A, Moots RJ. Complementary and alternative medicine use in Rheumatoid arthritis: Considerations for the pharmacological management of elderly patients. Drugs Aging 2017;34:255-64. https://doi.org/10.1007/s40266-017-0443-0
- Kolasinski SL. Herbal medicine for rheumatic diseases: promises kept? Curr Rheumatol Rep. 2012;14:617-23. https://doi.org/10.1007/s11926-012-0293-z
- 한국전통지식포탈의 약재/처방/병증 DB. Available from:http://www.koreantk.com/ktkp2014/medicine/medicine-view.view?medCd=M0000333, accessed 31/5/17.
- Georg S, Makiyeh TA, Josef SS, Beatrice JS, Carl-Walter S, Peter B, Peter Z, Kurt R, Qingbo X, Gunter S. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-jun N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheumatol. 2000;43:2501-12. https://doi.org/10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K
- Lindsey AM, Derrick JT. Kinase inhibitors: The next generation of therapies in the treatment of rhumatoid arthritis. Int J Rheum. Dis. 2014;17:359-68. https://doi.org/10.1111/1756-185X.12293
- Verica P, Margaret MH. Mitogen-Activated Protein kinases as therapeutic targets for rheumatoid arthritis. Drugs. 2013;73:101-15. https://doi.org/10.1007/s40265-013-0014-6
- Abdelhamid L, Judith S, Wen Qing L, Muhammad Z. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol. 2002;23:251-62.
- Jacques M, Francis B. Signal transduction pathways: new targets for treating rheumatoid arthritis. Joint Bone Spine. 2004;71:503-10. https://doi.org/10.1016/j.jbspin.2004.03.004
- Francois R, Mathias F, Marie TC, Francis, B. Cartilage breakdown in rheumatoid arthritis. Joint Bone Spine. 2006;73:29-36. https://doi.org/10.1016/j.jbspin.2004.12.013